Noramco
Noramco
Noramco
  • About Us
    • About Noramco
    • Our People
    • Leadership
    • Excellence in Compliance
    • Minimizing Risk
  • Products & Solutions
    • Active Pharmaceutical Ingredients
      • Active Pharmaceutical Ingredients
      • Nal Family of Antagonists
      • ADHD / Stimulants
      • Full Product List
    • Noramco Solutions
      • Noramco Solutions
      • Clinical Supply
      • Controlled Substance Building Blocks and Intermediates
    • Platform Technologies
      • Platform Technologies
      • Platform Technology: Custom Synthesis
    • Reference Standards
      • Reference Standards
      • Reference Standards: Custom Synthesis
    • Reference Standards Store
  • Careers
  • News & Events
    • News & Events
    • Press Releases
  • Contact

Sort by

  • Default sorting
  • Sort by popularity
  • Sort by newness
  • Sort by price: low to high
  • Sort by price: high to low

View

  • 9 items
  • 15 items
  • 30 items

Showing 1–9 of 12 results

  • 133_Noroxymorphone-Carbamate
    Quick ViewSelect options

    Noroxymorphone Carbamate (CII)

    $0.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 144265-46-3 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-2006-**
    Quick ViewSelect options
  • 132_Noroxymorphone-Base
    Quick ViewSelect options

    Noroxymorphone Base (CII)

    $350.00 – $1,400.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 33522-95-1 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-1022-**
    Quick ViewSelect options
  • 131_Naloxone-N-Oxide
    Quick ViewSelect options

    Naloxone N-Oxide (CII)

    $863.00 – $3,452.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 112242-14-5 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-2109-**
    Quick ViewSelect options
  • 130_Naloxone-Hydrochloride
    Quick ViewSelect options

    Naloxone Hydrochloride (NC)

    $575.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 357-08-4 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-2018-**
    Quick ViewSelect options
  • 129_Naloxone-Dimer
    Quick ViewSelect options

    Naloxone Dimer (CII)

    $1,438.00 – $5,752.00
    <span style="color: #000000;"><strong>OTHER NAMES:</strong></span> EP Impurity E; 2,2'-bisnaloxone <span style="color: #000000;"><strong>CAS#</strong></span> 211738-08-8 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-2041-**
    Quick ViewSelect options
  • 128_Naloxone-Base
    Quick ViewSelect options

    Naloxone Base (NC)

    $575.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 465-65-6 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-2017-**
    Quick ViewSelect options
  • 127_7,8-Didehydronaloxone-Base
    Quick ViewSelect options

    7,8-Didehydronaloxone Base (CII)

    $863.00 – $3,452.00
    <span style="color: #000000;"><strong>OTHER NAMES:</strong></span> EP Impurity D <span style="color: #000000;"><strong>CAS#</strong></span> 26451-92-3 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-2043-**
    Quick ViewSelect options
  • 126_3-O-Allylnaloxone
    Quick ViewSelect options

    3-O-Allylnaloxone Hydrochloride (CII)

    $863.00 – $3,452.00
    <span style="color: #000000;"><strong>OTHER NAMES:</strong></span> EP Impurity B <span style="color: #000000;"><strong>CAS#</strong></span> 1352085-46-1 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-2050-**
    Quick ViewSelect options
  • 125_3-O-Methylnaloxone
    Quick ViewRead more

    3-O-Methylnaloxone (CII)

    <span style="color: #000000;"><strong>OTHER NAMES:</strong></span> EP Impurity G <span style="color: #000000;"><strong>CAS#</strong></span> 70866-64-7 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-2048-**
    Quick ViewRead more
  • 1
  • 2

Recent Articles

  • Noramco CEO Lee Karras discusses $25 million Halo investment with PharmTech
  • Diversifying the Supply of Raw Materials
  • Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider
  • Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
  • Noramco Announces Submission and Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide
Copyright 2025 Noramco. All Rights Reserved. Contact | Legal Notice | Privacy Policy | Terms & Conditions | Benefits Transparency Mandate